Exact Sciences
EXAS
#1151
Rank
โ‚น1.724 T
Marketcap
โ‚น9,085
Share price
-0.23%
Change (1 day)
85.91%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2025 (TTM): -โ‚น456.52

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is -โ‚น476.76. In 2024 the company made an earnings per share (EPS) of -โ‚น499.16.

EPS history for Exact Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น456.52-8.54%
2024-โ‚น499.16
2022-โ‚น317.242.31%
2021-โ‚น310.07-38.54%
2020-โ‚น504.54692.96%
2019-โ‚น63.63-50.69%
2018-โ‚น129.0544%
2017-โ‚น89.62-39.39%
2016-โ‚น147.87-2.94%
2015-โ‚น152.3537.1%
2014-โ‚น111.1279.71%
2013-โ‚น61.84-21.59%
2012-โ‚น78.86

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Myriad Genetics
MYGN
-โ‚น388.04-18.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
โ‚น30.47-106.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Veracyte
VCYT
โ‚น34.95-107.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-โ‚น4,561 856.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น332.09-169.66%๐Ÿ‡ซ๐Ÿ‡ท France